When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OCUP - Ocuphire Pharma: An Undervalued Ophthalmic Play
Ocuphire Pharma Inc Com
Ocuphire is positioning itself as a leading ophthalmic player, providing novel therapeutic solutions for both front and back of the eye indications.
The company recently announced positive topline results for its lead candidate, Nyxol, in a Phase 3 study for Reversal of Mydriasis (RM) and in a Phase 2 study for Presbyopia.
The company is targeting multi-billion dollar market opportunities in four indications, which remain largely unmet, and in some cases with no approved therapies or competition.